Cargando…
Host genetic variation explains reduced protection of commercial vaccines against Piscirickettsia salmonis in Atlantic salmon
Vaccination is a widely used control strategy to prevent Piscirickettsia salmonis causing disease in salmon farming. However, it is not known why all the currently available commercial vaccines generally fail to protect against this pathogenic bacteria. Here, we report, from two different population...
Autores principales: | Figueroa, Carolina, Veloso, Pamela, Espin, Lenin, Dixon, Brian, Torrealba, Débora, Elalfy, Islam Said, Afonso, Juan Manuel, Soto, Carlos, Conejeros, Pablo, Gallardo, José A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588420/ https://www.ncbi.nlm.nih.gov/pubmed/33106499 http://dx.doi.org/10.1038/s41598-020-70847-9 |
Ejemplares similares
-
Commercial Vaccines Do Not Confer Protection against Two Genogroups of Piscirickettsia salmonis, LF-89 and EM-90, in Atlantic Salmon
por: Figueroa, Carolina, et al.
Publicado: (2022) -
Protein-Based Vaccine Protect Against Piscirickettsia salmonis in Atlantic Salmon (Salmo salar)
por: Pontigo, Juan Pablo, et al.
Publicado: (2021) -
Genomic predictions can accelerate selection for resistance against Piscirickettsia salmonis in Atlantic salmon (Salmo salar)
por: Bangera, Rama, et al.
Publicado: (2017) -
Non-lysosomal Activation in Macrophages of Atlantic Salmon (Salmo salar) After Infection With Piscirickettsia salmonis
por: Pérez-Stuardo, Diego, et al.
Publicado: (2019) -
Live and inactivated Piscirickettsia salmonis activated nutritional immunity in Atlantic salmon (Salmo salar)
por: Martínez, Danixa, et al.
Publicado: (2023)